REDUCED MORBIDITY IN CYSTIC FIBROSISGolding, Jean; Haslum, Mary; Carswell, F. · The Lancet · 1986

Appendicitis in cystic fibrosis: can morbidity be reduced?Susan E. Jacobs; Spencer W. Beasley; Colin F. Robertson; Keith B. Stokes · 1988

REDUCED MORBIDITY IN PATIENTS WITH CYSTIC FIBROSIS DETECTED BY NEONATAL SCREENINGWilcken, Bridget; Chalmers, Gwen · 1985

Pregnancy and fetal long-chain 3-hydroxyacyl coenzyme A dehydrogenase deficiencyWilcken, B.; Leung, K.-C.; Hammond, J.; Wilcken, B.; Kamath, R.; Leonard, J.V. · The Lancet · 1993

The pathogenesis of coronary artery disease. A possible role for methionine metabolism.Wilcken, D E; Wilcken, B · Journal of Clinical Investigation · 1976

Homocystinuria — The Effects of Betaine in the Treatment of Patients Not Responsive to PyridoxineWilcken, David E. L.; Wilcken, Bridget; Dudman, Nicholas P. B.; Tyrrell, Pauline A. · 1983

Neonatal screening for cystic fibrosisT Dudding; B Wilcken; B Burgess; G Turner · 2000

Clumsiness, confusion, coma, and valproateCJ Ellaway; B Bennetts; RR Tuck; B Wilcken · 1999

Homocysteine and Its Disulfide Derivatives : A Suggested Consensus TerminologyMudd, S. H.; Finkelstein, J. D.; Refsum, H.; Ueland, P. M.; Malinow, M. R.; Lentz, S. R.; Jacobsen, D. W.; Brattstrom, L.; Wilcken, B.; Wilcken, D. E. L.; Blom, H. J.; Stabler, S. P.; Allen, R. H.; Selhub, J.; Rosenberg, I. H. · Arteriosclerosis, Thrombosis, and Vascular Biology · 2000

Technical and economic efficiency of methods for extracting genomic DNA from Meloidogyne javanicaCarvalho, Vanessa Rafaela de; Wilcken, Sílvia Renata Siciliano; Wilcken, Carlos Frederico; Castro, Bárbara Monteiro de Castro e; Soares, Marcus Alvarenga; Zanuncio, José Cola · Journal of Microbiological Methods · 2019

How Trp repressor binds to its operator.Staacke, D.; Walter, B.; Kisters-Woike, B.; von Wilcken-Bergmann, B.; Müller-Hill, B. · The EMBO Journal · 1990